What is Agrivida?
Founded in 2004, Agrivida operates at the intersection of biotechnology and industrial agriculture. The company specializes in the research, development, and distribution of advanced enzymes designed to optimize animal nutrition and health. By leveraging sophisticated molecular biology, Agrivida provides solutions that enhance feed efficiency and sustainability, addressing critical challenges in modern food production. Its market position is bolstered by a robust intellectual property portfolio and a history of successful partnerships with major players in the life sciences and agtech sectors, allowing it to scale its operations from initial research to large-scale commercial deployment.
How much funding has Agrivida raised?
Agrivida has raised a total of $95.9M across 8 funding rounds:
Private Equity
$2M
Series C
$15.2M
Debt
$1.2M
Series D
$23M
Series D
$23M
Series E
$20.4M
Unspecified
$11M
Debt
$150K
Private Equity (2011): $2M, investors not publicly disclosed
Series C (2012): $15.2M led by DAG Ventures, Bright Capital, Alexandria, Presidio Ventures, PrairieGold Venture Partners, and Kleiner Perkins
Debt (2014): $1.2M, investors not publicly disclosed
Series D (2014): $23M featuring DAG Ventures, ARCH Venture Partners, Middleland Capital, Bright Capital Partners, PrairieGold Venture Partners, Northgate Capital, Cultivian Sandbox, and Kleiner Perkins
Series D (2015): $23M backed by Middleland Capital, Bright Capital Partners, ARCH Venture Partners, Gentry Venture Partners, Northgate Capital, Cultivian Sandbox Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures, and Prairie Gold
Series E (2016): $20.4M with participation from Northgate Capital, ARCH Venture Partners, Middleland Capital, Cultivian Sandbox, Kleiner Perkins, and University of Texas Investment Management Co.
Unspecified (2019): $11M led by ARCH Venture Partners, Middleland Capital, Batios Holdings Limited, Open Prairie Rural Opportunities Fund, Maschhoff’s Agricultural Holdings, Cultivian Sandbox, and Syngenta Ventures
Debt (2020): $150K supported by PPP
Key Investors in Agrivida
ARCH Venture Partners
A leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often co-founding startups with scientists to commercialize innovations.
Kleiner Perkins
A prominent Menlo Park-based venture capital firm that invests in early and growth-stage technology and life-science companies, providing capital and operational support from seed through IPO.
Cultivian Sandbox
A specialized venture firm focused on investing in innovative food and agriculture technology companies that address sustainable production and global food system security.
What's next for Agrivida?
Following the latest major strategic investment, Agrivida is well-positioned to accelerate its commercial expansion and deepen its penetration into international markets. The company's strategic roadmap likely involves scaling its enzyme production capabilities to meet the rising demand for sustainable animal feed additives. As the firm transitions further into its enterprise-level lifecycle stage, focus will likely shift toward optimizing operational efficiencies and exploring new applications for its core technology in broader foodtech verticals. Continued support from its diverse investor base provides the necessary runway to sustain innovation while navigating the complexities of the global agricultural landscape.
See full Agrivida company page
